Exotic Animal Formulary5

50 mg/kg IM, then Tortoises/Hermann’s tortoise; 27°C
25 mg/kg q72h 38,357 (81°F)
Enrofloxacin
5-10 mg/kg q24h PO,
SC, IM, ICe 117
Most species/IM administration is
painful and may result in tissue
necrosis and sterile abscesses;
may cause skin discoloration or
tissue necrosis if given SC; to
administer SC, dilute with
sterile NaCl
6.6 mg/kg IM q24h, or Pythons/PD (reticulated pythons);
11 mg/kg IM q48h 198 Pseudomonas
10 mg/kg IM
q48h 391,392,407
Snakes/PK (Burmese pythons,
rattlesnakes, pit vipers)
5 mg/kg PO, IM q24h 255 Lizards/PD (green iguanas);
marked pharmacokinetic
variability with PO
administration may make IM
more suitable in critically ill
animals
10 mg/kg IM q5d 160 Monitors/PK (savannah monitors);
preliminary data
5 mg/kg IM q24-48h 310 Chelonians and most other
reptiles/PD (gopher tortoises);
hyperexcitation,
incoordination, diarrhea
reported in a Galapagos
tortoise 49
5 mg/kg IM q12-24h 320 Chelonians/PK (Indian star
tortoises); q12h for Pseudomonas
and Citrobacter; q24h for other
bacteria
5 mg/kg IV, IM q48h 210 Sea turtles/PK (loggerhead sea
turtles)
10 mg/kg ICe q48h 123,332 Chelonians/PD (Hermann’s
tortoises; yellow-bellied sliders)
dilute with saline to 10 mg/mL
10 mg/kg IM q24h 357 Chelonians/PD (Hermann’s
tortoises)
5 mg/kg IV q36-72h 146,250 Crocodilians/PK; PO
pharmacokinetics not fully
determined; mycoplasmosis
Nasal flush
Tortoises/URT syndrome; use until
131